Analyst Price Targets — DCGO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 12, 2025 11:42 am | Richard Close | Canaccord Genuity | $1.50 | $1.10 | StreetInsider | DocGo (DCGO) PT Lowered to $1.50 at Canaccord Genuity |
| February 28, 2025 1:47 pm | — | Deutsche Bank | $2.85 | $3.09 | TheFly | DocGo downgraded to Hold from Buy at Deutsche Bank |
| May 9, 2024 6:44 am | Richard Close | Canaccord Genuity | $5.00 | $3.50 | StreetInsider | DocGo (DCGO) PT Lowered to $5 at Canaccord Genuity |
| April 10, 2024 6:58 am | David Grossman | Stifel Nicolaus | $8.00 | $3.17 | StreetInsider | DocGo (DCGO) PT Lowered to $8 at Stifel |
| April 10, 2024 4:58 am | David Larsen | BTIG | $11.00 | $3.85 | StreetInsider | DocGo (DCGO) PT Lowered to $11 at BTIG |
| April 19, 2022 8:52 am | — | Deutsche Bank | $11.00 | $8.11 | Benzinga | Deutsche Bank Initiates Coverage On DocGo with Buy Rating, Announces Price Target of $11 |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for DCGO

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that the Company will release its financial results for the fourth quarter and full year ended December 31, 2025, after the markets close on Monday, March 16, 2025. Management will also host a conference call to discuss these…

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that Lee Bienstock, Chief Executive Officer, will participate in 1x1 meetings at the TD Cowen 46th Annual Health Care Conference on Monday, March 2nd, and will deliver a presentation at 9:10 AM ET on that day. A webcast of the event will be available on the investor…

DocGo Inc. (NASDAQ: DCGO - Get Free Report) has earned a consensus rating of "Hold" from the seven analysts that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and two have issued a buy recommendation on the company. The average

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that its virtual care division, SteadyMD, is undertaking an immediate expansion of its clinical workforce, with plans to increase clinical staff by up to 50% over the coming weeks. The hiring initiative is driven by accelerating…

DocGo Inc. (NASDAQ: DCGO - Get Free Report) has earned an average recommendation of "Hold" from the seven analysts that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DCGO.
U.S. House Trading
No House trades found for DCGO.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
